ALFA Finder| EBITDA Margin guidance | 22.5% → 23.0% Raised by 0.5 percentage points |
|---|
| Revenue growth | 51% YoY growth; USD revenue up 32% YoY to $55 million. |
|---|---|
| Margins | Gross margin up 140 bps sequentially to 67.7%; Operating EBITDA at 24.2%. |
| Demand visibility | Strong traction for revenue; very strong visibility in coming quarters. |
| Management confidence | High; citing strong visibility and broad-based growth across portfolio. |
Growth
Revenue grew 51% YoY; EBITDA rose 65% to ₹131 Cr; Operating EBITDA margin expanded to 24.2%.
Outlook
EBITDA guidance for FY27 raised to 23% (from 22-23%). Pithampur and NJ facilities to ramp up by CY2027.
Risks
Geopolitical conditions increasing input and freight costs; new facility pre-revenue costs; ESOP costs impacting near-term margins.
Last quarter's promises, checked
Delivered
- EBITDA range 22-23% → delivered 24.2% (= BEAT)
- R&D productivity 5.7x → delivered 5.9x (= BEAT)
- Pithampur ramp-up Q1 CY27 → on track/pre-revenue (= BEAT)
Partly delivered
- Gross margins to improve via internal mfg → reliance on outsourcing remains high (= PARTIAL)
Investor Presentation filed with BSE, NSE: RUBICON. Summary written with AI assistance from the document.
Rubicon Research Ltd: key numbers
- Share price
- ₹1,734.00
- Market cap
- ₹28,703 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹246.7 Cr
- P/E (TTM)
- 88.4×Sector 43.8×
- Promoter holding
- 51.25%-8.51% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rubicon Research Ltd
All →Rubicon Research Earnings Call Transcript: Key Takeaways
Q2 revenue rose 40% to ₹576 Cr with 25% operating EBITDA margin and ₹90 Cr PAT. Arena acquisition flatters growth, and recent plant inspections remain unresolved.
Rubicon Research Other Announcement
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Rubicon Research Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Rubicon Research Q2 FY27 Results: Net Profit ₹90.4 Cr, Up 67.7% YoY
Rubicon Research Ltd reported revenue from operations of ₹576.4 Cr (+39.9% YoY) and net profit of ₹90.4 Cr (+67.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹90.4 Cr · +67.7% YoY
Rubicon Research Employee Stock Options
Rubicon Research Limited granted 68,982 stock options at an exercise price of Rs. 1,374.40 per share. The options vest over five years under the company's 2026 ESOP plan.
Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.